These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3157886)

  • 21. An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain.
    Lloyd KG; Dreksler S
    Brain Res; 1979 Mar; 163(1):77-87. PubMed ID: 218679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of GABA metabolism: implications for Huntington's disease.
    Schwarcz R; Bennett JP; Coyle JT
    Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of principles of steady-state kinetics to the estimation of gamma-aminobutyric acid turnover rate in nuclei of rat brain.
    Bertilsson L; Mao CC; Costa E
    J Pharmacol Exp Ther; 1977 Feb; 200(2):277-84. PubMed ID: 839439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain GABA levels in asymptomatic Huntington's disease.
    Reynolds GP; Pearson SJ
    N Engl J Med; 1990 Sep; 323(10):682. PubMed ID: 2143559
    [No Abstract]   [Full Text] [Related]  

  • 25. Further investigations on brain distribution of hydrazine and its gamma-aminobutyric acid elevating effect in rats.
    Matsuyama K; Yamashita C; Sendoh T; Noda A; Goto S; Iguchi S
    J Pharmacobiodyn; 1983 Dec; 6(12):932-7. PubMed ID: 6674479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The brain in Huntington's chorea.
    Bird ED
    Psychol Med; 1978 Aug; 8(3):357-60. PubMed ID: 151869
    [No Abstract]   [Full Text] [Related]  

  • 29. What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies.
    Perry TL; Hansen S
    Neurology; 1990 Jan; 40(1):20-4. PubMed ID: 1967491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 31. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea.
    Hiley CR; Bird ED
    Brain Res; 1974 Nov; 80(2):355-8. PubMed ID: 4278580
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
    Dawbarn D; De Quidt ME; Emson PC
    Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

  • 38. Brain homocarnosine and seizure control of patients taking gabapentin or topiramate.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2006 Mar; 47(3):495-8. PubMed ID: 16529611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical effects in man and rat of three drugs which can increase brain GABA content.
    Perry TL; Hansen S
    J Neurochem; 1978 Apr; 30(4):679-84. PubMed ID: 148494
    [No Abstract]   [Full Text] [Related]  

  • 40. GABA and neuropsychiatric disorders.
    Enna SJ
    Can J Neurol Sci; 1980 Aug; 7(3):257-9. PubMed ID: 6449991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.